Dr. Paul Saladino's Peptide Breakdown: "No Biological Free Lunch"

Dr. Paul Saladino — a board-certified MD better known as a prominent animal-based / carnivore-diet advocate — put out a video titled "Peptides Explained: Best Peptides and Reasons to Reconsider." It's a deliberately contrarian take: peptides are the most viral topic in health right now, and his thesis is that most of them are a shortcut with a hidden bill — "there is no biological free lunch."

He's an opinionated narrator, and it's worth flagging up front which parts are established science versus his personal framing. We've done that throughout: the gray-market quality data and the basic peptide pharmacology are solid and line up with the wider literature; the "just fix your diet first" and "getting lean wrecks your hormones" arguments are his strongly-held positions, presented here as his. Nothing below is medical advice, and several compounds discussed are not approved for human use.

The framing: what a peptide actually is

A peptide is just a short chain of amino acids — technically a protein under ~50 of them. Saladino's useful reminder is that your body already makes hundreds: insulin, ghrelin, GLP-1, oxytocin, even BPC-157 (which occurs naturally in gastric secretions). Most "peptide therapy" is just injecting a synthetic mimic of one of these endogenous signaling molecules, because if you swallowed most of them your stomach would digest them into amino acids (the lone mainstream exception being oral semaglutide, which Novo Nordisk engineered to survive stomach acid).

The part that applies to everyone: gray-market quality

Before any specific compound, Saladino hammers the sourcing problem, and this is the most universally important section — it's backed by hard data:

Gray-market peptides arrive as powders from Chinese factories stamped "for research purposes only," which nobody buying them is actually doing.
A 2024 study in the Journal of Medical Internet Research tested injectable semaglutide bought online and found measured purity as low as 7.7% against a labeled 99% — i.e., the overwhelming majority of what people injected was not the drug. Every product tested was classified as substandard, falsified, or counterfeit.
A bipartisan coalition of 38 state and territory attorneys general formally petitioned the FDA over a "national ecosystem of counterfeit, contaminated, and research-grade peptides" entering the US through unregulated channels.

His point stands regardless of where you land on the rest: with gray-market product, you frequently don't know what's in the vial. (This is the exact problem independent COA verification exists to address — see any compound's research page for what a credible certificate of analysis should show.)

Class 1 — GLP-1s (semaglutide, tirzepatide, retatrutide)

The mechanics he lays out are accurate. GLP-1 ("glucagon-like peptide-1") is released when you eat and normally lasts only minutes before the enzyme DPP-4 degrades it. The drugs (originally derived from Gila monster saliva) are ~94% identical to your own GLP-1 but modified to resist DPP-4 and stick around for days, so they blunt appetite far longer than the natural signal. Tirzepatide adds a GIP agonist; retatrutide is the triple agonist (GLP-1 + GIP + glucagon) still in trials. See the retatrutide, semaglutide, and tirzepatide research pages for the trial detail.

His concerns, which are legitimate and well-documented:

Muscle loss / "Ozempic bod." Because you eat so little, you can lose significant lean mass and bone density alongside fat — what he calls sarcopenia and frailty.
Regain. The research he references shows weight regain after stopping can be fast (he cites ~4× faster than if you'd stopped exercising), because the drug doesn't teach any durable habit.
Dependency. His biggest worry: a nation of people permanently dependent on a GLP-1 rather than addressing root causes.
Retatrutide's dose-dependent heart-rate increase, with unknown long-term effects.

Where it shifts to his opinion: his prescription is essentially "eat single-ingredient real food first, the weight comes off without the drug." That's his carnivore/animal-based worldview, and he's candid that for someone 100–200 lb overweight who won't or can't change their diet, a GLP-1 may genuinely be net-positive. The honest synthesis: GLP-1s are powerful and real, they help the people who need them most, and the muscle-loss/regain trade-offs are documented — not hype.

Class 2 — Recovery peptides (BPC-157, TB-500)

The "Wolverine stack." Saladino's evidence read matches ours closely: BPC-157's animal data comes overwhelmingly from a single Croatian research group, with extremely thin human data; TB-500 has essentially zero human data. He shares that he used BPC-157 once (for neck trauma after a surfing accident) and noticed no dramatic change.

His sharpest point is the angiogenesis–cancer concern: both peptides promote new blood-vessel formation via VEGF, and since most cancers depend on angiogenesis to grow, chronically dialing up baseline angiogenesis is a theoretical way to feed an existing tumor. (He did his college molecular-biology research on angiogenesis, so this is his wheelhouse.) His practical take: don't use these chronically — possibly cycle for a genuine acute injury, but not as an everyday gym-recovery habit. Full evidence on the BPC-157 and TB-500 research pages, including the same single-group caveat.

Class 3 — Growth-hormone secretagogues (CJC-1295 / ipamorelin; sermorelin)

These don't add growth hormone directly — they prompt your pituitary to release more of its own. Saladino's nuance is good here: injected HGH produces a flat, tonic elevation, whereas the CJC-1295 + ipamorelin combination produces a pulsatile release that better mimics natural GH rhythm (ipamorelin mimics ghrelin; CJC-1295 mimics growth-hormone-releasing hormone). Sermorelin is an FDA-approved secretagogue in this family. See ipamorelin, sermorelin, and tesamorelin.

His cautions:

These are "permissive anabolics" — they help you build muscle only if everything else (training, food) is dialed; the gains fade within weeks of stopping.
Too much GH has real downsides: insulin resistance, worse metabolic health, and elevated IGF-1, which is associated with higher cancer rates. He invokes acromegaly — the disease of chronic GH excess — as the cautionary extreme, pointing to Andre the Giant (a pituitary tumor drove constant GH release; he had the enlarged features, arthritis and chronic pain, an enlarged heart, and died at 46 of congestive heart failure) and Tony Robbins (who has managed acromegaly, hence the famously large hands, feet, and broad jaw). The point: the body didn't evolve to run high GH around the clock.
Stacking GH secretagogues with BPC-157/TB-500 means multiple simultaneous pro-growth signals, and the long-term combined effect is simply unknown.

Class 4 — Melanotan (and a word on exercise mimetics)

His verdict on melanotan is blunt: don't. It's a synthetic melanocortin-receptor agonist that tans you without sun, never FDA-approved, and there are reports of it reactivating dormant melanomas or increasing melanoma incidence in animals and humans. Melanoma isn't a cancer to gamble with. (Background on the melanotan profile.)

On exercise mimetics like MOTS-c, his take is simpler still: why not just exercise and let your body make the peptide itself? See MOTS-c.

His most opinionated argument: the body-fat / hormone trade-off

This is the section that's most Saladino rather than settled consensus, so read it as his framing. His claim: chasing extreme leanness — whether via GLP-1s or crash dieting — tanks your sex hormones. He describes a U-shaped curve where both too-high and too-low body fat suppress testosterone in men, and cites research suggesting that above ~15% body fat, every additional 1% of body fat drops testosterone by roughly 12 points — but that dipping below ~8% also tanks it. His male sweet spot: around 10–12%. For women he puts the healthy range at 18–24%, noting that some elite athletes hold 15–16% and keep a normal cycle, but most women who get that lean lose their period and fertility.

His most pointed move is naming his friend Robert Breedlove (with permission): at 37, Breedlove was reportedly ~11% body fat, natural, with normal testosterone and working testicles. Now, lean to ~5–6% on retatrutide, he's also on exogenous testosterone and anabolics — which, Saladino argues, is the tell: you can get shredded on a GLP-1, but at that leanness you're either on testosterone or your own production is cratering. His blunt summary of stage-lean bodybuilders and bikini competitors: they are not hormonally healthy — most are on exogenous hormones, the women often aren't menstruating, and "if these two people came together they're not going to make any baby because they're both infertile."

He closes the loop with himself: at 48, he says he eats single-ingredient food, sits around 10–11% body fat (verified by DEXA, he claims), takes no peptides/TRT/steroids, and last checked his testosterone at 850 against an average male's ~450. (He even mentions betting a skeptic "a lot of ribeyes" he'd pass a drug test.) The underlying physiology — that extreme leanness disrupts hormones — is real and well-documented. The specific cutoffs, the "850 proves it" flex, and the "so don't get shredded with a GLP-1" conclusion are his interpretation, rooted in his animal-based worldview.

The through-line: no biological free lunch

Strip away the carnivore-diet evangelism and the core message is one this site agrees with: every one of these compounds is a real signal with real trade-offs, and the evidence behind them varies enormously. GLP-1s have the deepest data and genuinely help the obese; the recovery and GH peptides rest on much thinner ground with open cancer questions; melanotan he'd avoid outright. The universal lesson is the same as the framing he opened with — know which tier of evidence you're standing on for each specific compound, and with the gray market, demand proof of what's actually in the vial.

Every compound named here has a fully-referenced research page that lays out the mechanism, the trial sizes, and the honest evidence limits — the best place to go deeper on any one of them.

This article is an independent summary and analysis of a public YouTube video for educational purposes. It is not affiliated with or endorsed by Dr. Paul Saladino. His dietary positions and risk interpretations are his own and are presented as such. It is not medical advice; several compounds discussed are not approved for human use. Confirm any claim against primary sources before relying on it.